ASRT Stock | | | USD 0.95 0.01 1.04% |
Assertio Therapeutics financial indicator trend analysis is way more than just evaluating Assertio Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Assertio Therapeutics is a good investment. Please check the relationship between Assertio Therapeutics Net Income From Continuing Ops and its Operating Income accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Assertio Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Assertio Stock please use our
How to Invest in Assertio Therapeutics guide.
Net Income From Continuing Ops vs Operating Income
Net Income From Continuing Ops vs Operating Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Assertio Therapeutics Net Income From Continuing Ops account and
Operating Income. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Assertio Therapeutics' Net Income From Continuing Ops and Operating Income is 0.85. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Operating Income in the same time period over historical financial statements of Assertio Therapeutics, assuming nothing else is changed. The correlation between historical values of Assertio Therapeutics' Net Income From Continuing Ops and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Assertio Therapeutics are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Net Income From Continuing Ops i.e., Assertio Therapeutics' Net Income From Continuing Ops and Operating Income go up and down completely randomly.
Correlation Coefficient | 0.85 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Net Income From Continuing Ops
Operating Income
Operating Income is the amount of profit realized from Assertio Therapeutics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Assertio Therapeutics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most indicators from Assertio Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Assertio Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Assertio Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
For more information on how to buy Assertio Stock please use our
How to Invest in Assertio Therapeutics guide.At this time, Assertio Therapeutics'
Selling General Administrative is comparatively stable compared to the past year.
Tax Provision is likely to gain to about 81.8
M in 2024, despite the fact that
Enterprise Value Over EBITDA is likely to grow to
(0.19).
Assertio Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Assertio Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Assertio Therapeutics fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Assertio Stock Analysis
When running Assertio Therapeutics' price analysis, check to
measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.